This Month in JAAD Case Reports: June 2023 Spesolimab for Pyoderma Gangrenosum.
| Publicado en: | Journal of the American Academy of Dermatology Vol. 88; no. 6; pp. 1261 - 1262 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
Elsevier B.V.
Jun2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164020712&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 164020712 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01909622 1ZF jtl: Journal of the American Academy of Dermatology issn: 01909622 maglogo: N pubinfo: dt: Jun2023 vid: 88 iid: 6 pid: 467 pub: Elsevier B.V. place: New York, New York artinfo: ui: 164020712 10.1016/j.jaad.2023.03.007 164020712 ppf: 1261 ppct: 1 formats: tig: atl: This Month in JAAD Case Reports: June 2023 Spesolimab for Pyoderma Gangrenosum. aug: au: Sloan, Brett affil: Department of Dermatology, University of Connecticut School of Medicine, Farmington, Connecticut sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|